|
PLS effect size
|
AON/MOL
|
AON/ORB
|
ORB/MOL
|
ORB/CV
|
MOL/ZP
|
ZP/CV
|
ZP/CB
|
---|
AON/MOL
|
7.49
| | | | | | | |
AON/ORB
|
4.71
|
1.1e−01
| | | | | | |
ORB/MOL
|
6.18
|
3.5e−01
|
5.7e−01
| | | | | |
ORB/CV
|
3.28
|
9.1e−03*
|
3.5e−01
|
9.6e−02
| | | | |
MOL/ZP
|
3.24
|
9.1e−03*
|
3.4e−01
|
7.3e−02
|
9.1e−01
| | | |
ZP/CV
|
7.19
|
5.7e−01
|
3.4e−01
|
6.9e−01
|
3.2e−02*
|
3.0e−02*
| | |
ZP/CB
|
4.01
|
6.6e−02
|
7.3e−01
|
3.5e−01
|
5.7e−01
|
5.5e−01
|
1.9e−01
| |
CB/CV
|
3.63
|
3.2e−02*
|
6.0e−01
|
2.6e−01
|
6.9e−01
|
6.5e−01
|
1.1e−01
|
7.9e−01
|
- The p-values were adjusted using a Benjamini–Hochberg correction
- AON anterior oral-nasal, ORB orbital, MOL molar, CB basicranium, ZP zygomatic-pterygoid, CV cranial vault